Abstract
Obstructive sleep apnea hypopnea (OSAH) has a high prevalence in cardiac patients and adversely affects treatment outcome. OSAH induces profound changes in right ventricular (RV) function with repetitive oxidative stress to the cardiovascular (CV) system, thus increasing the risks for refractory hypertension, pulmonary hypertension, acute coronary syndrome, heart failure, stroke, malignant arrhythmias and even sudden cardiac death. This study evaluates a new method for monitoring the impact of OSAH on the CV system.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
